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Abstract
Background: In Nigeria, glaucoma has a high prevalence and is the second cause of blindness among adults after
cataract. People with glaucoma frequently present very late with advanced disease, and acceptance of and
adherence to treatment is low. The purpose of the study was to explore how patients’ understand and respond to
glaucoma in order develop an intervention to improve adherence to treatment.
Method: Hospital based qualitative study. Six focus group discussions were held with patients with advanced
disease and who had either undergone glaucoma surgery, were receiving medical treatment, or had neither
surgery nor medical treatment. Two traditional healers who treat eye conditions were interviewed. Audio files
were transcribed, translated into English and recurring themes coded and categorized as the impact of vision
loss, and understandings of the disease and its management.
Results: Visual loss impacted significantly on the lives of people with glaucoma in many ways. Many heard the
term “glaucoma” for the first time during the study. Local terms to describe the symptoms included Hawan jinin
ido (“hypertension of the eye”). Patients sought treatment in pharmacies, or with traditional healers who had
different interpretations of glaucoma and its treatment to biomedical understandings. Cost and forgetfulness
were the main reasons for low adherence to treatment while fear was a reason for not accepting surgery. Lack
of money and negative staff attitudes were reasons for low follow up.
Conclusion: Halting the progression of glaucoma is possible with treatment but the condition will remain a
“silent thief of sight” in West Africa unless awareness, uptake of services and adherence to treatment improve.
Understanding how glaucoma is locally conceptualised, lived with and responded to by patients is essential to
aid the design of interventions to prevent glaucoma blindness in Africa. Findings have been used to adapt a
motivational interviewing intervention, which is being evaluated in a clinical trial.
Keywords: Glaucoma, Behaviour, Adherence, Treatment, Africa, Awareness, Acceptance, Traditional medicine
Background
Glaucoma is the second commonest cause of blind-
ness worldwide after cataract [1] and is the leading
cause of irreversible blindness. In Nigeria, over one
million people are estimated to be blind (0.78 % of the
population), with 16.3 % attributed to glaucoma [2].
Together with its high prevalence, glaucoma in Africa
is characterised by an early age of onset and aggressive
disease course [3], Early presentation and treatment
are essential to reduce the incidence of blindness.
However, studies in Africa show that a high propor-
tion of affected individuals only present once they are
already blind in one or both eyes [3–10]. Once diag-
nosed, adherence to medical treatment is reported to
be low [11] with high dropout rates [12, 13]. Surgical
treatment is often not accepted or fails to control pro-
gression [11, 14, 15].
Understanding the way the symptoms and diagnosis of
glaucoma are conceptualised lived with and responded
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to is essential to guide the design of interventions to in-
crease early attendance for diagnosis and acceptance of
treatment. Studies from around the world have identified
the problem of low adherence or drop out from glau-
coma treatment [16–19], being associated with poor
knowledge of glaucoma [20–24], low levels of education
[25, 26], black ethnicity [12, 27–31], worsening visual field
loss [32], increasing age [28, 33, 34], lack of access to
medication, inability to instil eye drops and forgetting to
use the treatment [35–38]. Few studies have investigated
this in African populations, although low awareness of the
disease [39, 40], and fear and cost of treatment have been
reported [41]. A diagnosis of glaucoma is often the first
time a layperson encounters the disease [42–46].
The purpose of this study was to explore how patients
understand and respond to glaucoma in Bauchi, north-
east Nigeria: what they know about the disease, how
they conceptualise its treatment and how they manage
it, the family support and alternative sources of treat-
ment. Traditional healers were interviewed to triangulate
patients’ responses.
The study was undertaken in the eye clinic of Abubakar
Tafawa Balewa University Teaching Hospital (ATBUTH)
in Bauchi. The population are mainly subsistence farmers
and levels of education are low. 70 % of the population live
below the poverty line [47]. The catchment area of the
hospital is approximately 4 million. Eye care is also pro-
vided in the State by another government hospital and a
private mission clinic. Most expenses are covered by out
of pocket payments by patients. Some government and
private company workers have access to health insurance.
Many people, particularly in rural areas, rely on traditional
healers, who are mostly herbalists.
Methods
Focus group discussions (FGDs) were undertaken with
glaucoma patients identified in the eye department at
ATBUTH. Traditional healers who treat patients with
eye problems were also interviewed to elicit additional
insights into patient perceptions and management of
glaucoma. Topic guides were developed and used with
probe questions to aid discussion as necessary.
Participants
Six FGDs were undertaken. Three sub-groups of patients
with late glaucoma in at least one eye were recruited:
those who had undergone surgery, those on medication
and those currently not on treatment, (Table 1). Late
disease was defined as a visual acuity of less than count-
ing fingers in at least one eye due to glaucoma. Eligible
glaucoma patients were identified in the outpatient de-
partment using standard clinical methods. Further in-
clusion criteria included being resident in the state for
at least 6 months, an ability to understand Hausa or
English and willingness to participate. Separate FGDs
were held with men and women to encourage open re-
sponses rather than to elicit gender differences. Escorts
of the same gender were permitted to attend. Patients
understood that their responses would be used for
intervention design and completion of academic studies
by the researcher. The FGDs took place in a quiet room
in the hospital and each FGD comprised 7–11 patients
and 1–3 escorts, and discussions typically lasted for 1–
2 hours. Two traditional healers, who were identified
by asking patients who they had visited, were inter-
viewed in their homes, which also doubled as their
places of work. Interviews and FGDs were conducted
by a female social scientist experienced in counselling
and interviews. Discussions were audio recorded with
permission from the group. A note taker recorded add-
itional observations. The lead investigator (MA, a male)
was present only during interviews with the traditional
healers who were both male.
Data management
All records from discussions and interviews, including
written notes, audio files and summaries of each event
were linked by unique identifiers and stored securely.
Audio files were transcribed verbatim into Hausa and
proofread against the audio file by both the interviewer
and the lead researcher for accuracy. Transcripts were
then translated from Hausa into English and rechecked
by the researcher (MA). A meaning-based translation ap-
proach was used: where there was no terminology for a
word in English it remained in Hausa. All audio files, tran-
scripts, translations and summary notes were uploaded
Table 1 Glaucoma patient study sub-groups and topics
Sub-group Topics of particular interest
Late glaucoma patients who had undergone surgery To gain insights into what motivated them to accept surgery.
What their fears were prior to their decision and how they overcame them.
Late glaucoma patients who were on medication To explore the motivation behind their reported adherence to medication
while facing a real threat to their vision. To explore coping techniques used
to ensure availability of their drugs and adherence. To explore if they were
ever offered surgery to find out why they did not accept it.
Late glaucoma patients who had not undergone surgery
and were not on medication
To explore reasons for presenting very late to hospital, accepted surgery
or medication. To try to understand the barriers they could not overcome.
Abdull et al. BMC Ophthalmology  (2016) 16:44 Page 2 of 9
into Nvivo for coding and analysis. The analysis was
undertaken using the Hausa transcript by the researcher
who is bilingual in Hausa and English. Relevant sections
of transcripts and observers’ notes were used in the ana-
lysis to explore recurring themes, which were coded in
NVivo software (QSR International). These were cate-
gorized by the researcher in consultation with the inter-
viewer as an ongoing process through the fieldwork,
according to the topics of interest i.e.understanding of
glaucoma, adherence to medication, their views on
traditional healers, acceptance of surgery and follow up,
family support and problems faced because of glau-
coma. The analysis followed a meaning-based approach,
whereby themes were seen as emergent from the inter-
action between researchers, their questions and re-
search subjects. Only themes considered strongly
represented in the data are presented. Samples of the
interviews were read by CC and CG in order to con-
verge on the most salient themes to answer the re-
search questions. Relevant quotes presented in this
paper were extracted from the English translation.
Results
Sixty-six patients participated, approximately half of
whom were male. Approximately a fifth were escorts
who were usually close relatives or spouses who live with
and care for the patients. Many patients were happy to
talk about their condition and it seemed important to
them that someone cared enough to listen. None refused
invitation to participate and participants were not in-
vited back to provide feedback on the findings.
Understanding of glaucoma
Despite having late stage disease, many said they heard
the term “glaucoma” for the first time during this study.
Those familiar with the term had heard it from hospital
staff after diagnosis. However, people were familiar with
the symptoms, but not universally.
The peripheral field loss characteristic of glaucoma
was graphically described by some, as Taka shanya
which describes stumbling when walking looking
straight ahead and Ciwon dundumi which means
“groping illness”, a common term in areas where on-
chocerciasis (“river blindness”) is endemic. Some used
more general terms such as Hazon ido, which means
cloudy vision, and Yanar ido, which is commonly used
to describe cataract. Some attributed the symptoms to
Hawan jinin ido, which literally means hypertension
of the eye, or Amosanin kai, which means dandruff of
the scalp.
Given the multiple local constructs relating to the sin-
gle biomedical category of glaucoma, it is not surprising
that multiple causes of these symptoms were reported.
“It is caused by high blood pressure”. FGD 01-M52
“Bleeding in the eye as a result of accident can bring
about glaucoma”. FGD 02-F52
“Being possessed by evil spirits which attack the eye”.
FGD 05-M33
“Apollo infection can turn into glaucoma”. FGD 03-M43
Apollo is a local name for a highly infectious form of
viral keratoconjunctivitis, which occurs in epidemics in
West Africa. Other causes included eating processed
food, exposure to cold, prolonged crying/mourning, and
frequent exposure to smoke from fires. However, many
respondents admitted that they did not know what
causes this eye condition.
Perceived threats because of blindness
Visual loss from glaucoma leads to disruption in every-
day life and can have a major impact on activities, social
standing and aspirations, which were described vividly
by some. Table 2 describes the impact of blindness from
glaucoma according to Khadka, and adherence to treat-
ment regrouped according to Newman-Casey [48, 49].
Coping with loss of vision was a major issue. Some
were able to cope with family support while others har-
boured resentment. Loss of job, self esteem or profession
were major issues. A young man had this to say.
“This sickness has affected our ambition and killed
our dreams”. FGD 06-M47
Glaucoma patients described different forms of
support from family and friends, and some spoke of
the burden their condition placed upon these carers.
Sometimes the responses of others were not
supportive:
“My neighbour was happy I was on my way to
blindness”. FGD 06-F56
Seeking treatment
Patients sought treatment in a variety of places. Some
went to pharmacies to purchase eye drops or seek advice
about treatment while others consulted friends or neigh-
bours. Some respondents described visiting traditional
healers before coming to the hospital and there were a
range of responses (Table 2).
“Traditional medicine is trial and error”. FGD 04-M31
“It is possible to get cure from traditional herbs
because most of the modern medicine we use are
processed from traditional herbs”. FGD 03-M52
In-depth interviews with traditional healers
Traditional healers were often visited first by patients
before attending hospital while others visited healers as
a last resort.
Abdull et al. BMC Ophthalmology  (2016) 16:44 Page 3 of 9
“Most patients come to us after losing hope in the
medications offered by the hospitals they visited” IDI
02–1
One traditional healer had strong views about the
causes of glaucoma and how it should and should not be
treated:
“Glaucoma and cataract are like younger and older
brothers. They are caused by the bite of flies known
as ‘fuleria’. Once bitten by the carrier fly, a person is
afflicted by the ailment and can carry the germ for up
to 3 years or 4 years or sometimes for up to 5 years
before it affects the mucus of the eye….once it starts
the poison now changes the mucus to something like
groundnut oil and becomes a cataract. If it is
becoming glaucoma it doesn’t separate - it mixes to
Table 2 Examples of participant responses on specific topics
about glaucoma
Impact of glaucoma and blindness from glaucoma
Emotional well-being
“This sickness has affected our ambition and killed our dreams”.
FGD 06-M47
“As human nature, relatives, friends and neighbours sometimes avoid
us. In fact the relationship is not the same again”. FGD 03-M62
“Our relatives are trying their best but sometimes they get tired”.
FGD 06-F69
“I wanted to study so much but I got this disease at secondary
school. I am not happy about it since I was one of the best
students in school. I still dream about school”. FGD 02-F40
Social issues
“This sickness has also affected our roles and the status we occupy
at home and in society generally”. FGD 06-M47
“The sickness affects our social activities. For example, we cannot
attend some social gatherings”. FGD 06-F50
Economic issues
“I cannot do the work I used to do before the onset of this
sickness”. FGD 03-M30
“I am a professional and I cannot do my job now. I used to farm
very well but now I cannot do it. Lack of sight has deprived me of
many things” FGD 03-M51
Resilience
“When one is blind, he/she just has to tolerate and bear certain
things”. FGD 01-F22
Impact on family and relationships
“Relations show concern and care to our sickness”. FGD 01-F40
“My sickness affects every activity my relatives are engaged in. For
example they have left their farms, business, work and little ones
alone just to be with us here in the hospital”. FGD 04-F50
“Family and relatives help us in most of our chores, but they may
not do everything the way we want it done”. FGD 04-F52
Seeking treatment
“My neighbour prescribed my eye drop for me when I told him I
have glaucoma because he also has the same illness. FGD 01-M57
“I don’t think glaucoma or any other eye problem has traditional
cure. This is because traditional healers don’t have equipment to
test any eye disease”. FGD 04-M26
“I once use traditional herb, but there was no improvement”
“Traditional healers use one herb to treat many different ailments,
so they can be very dangerous”.FGD 01-F45
“I once met a traditional leader who told me my problem was
glaucoma. He wanted to operate on my eye but my colleagues
warned me and said if the surgery does not work, where will you
see the man to complain or sue him in the court when my eyes
go blind? So I opted out and refused the operation” FGD 05-M32.
Adherence to treatment
Forgetfulness
“We try our best to use the drugs as prescribed, but it is natural as
human beings to forget once in a while”. FGD 03-F35
Beliefs about medication / side effects
“I don’t intend to use the drugs for too long because I believe that
long term usage can cause complications for me” FGD 01-M54
Table 2 Examples of participant responses on specific topics
about glaucoma (Continued)
Medication of no benefit
“As a blind person, I no longer use the drugs because I feel they
are not useful to me since I cannot see”.
“There was a time I defaulted because the drugs were not working
for me”. FGD 01-M54
Satisfaction with medication
“I am happy using eye drops but would prefer to be given
spectacles” FGD 05-M49
“Drugs have helped to prevent the remaining part of my eye from
complete blindness”. FGD 05-M49
Acceptance of surgery
“I know people that have undergone glaucoma surgery and they are
seeing better now”.
“My sister was completely blind, but doctor X performed surgery and
it was successful, but I don’t know if her case was glaucoma”. FGD
06-F69
“I have had surgery and can testify that I can see better after the
surgery than I was seeing before the surgery too”. FGD 01-M43
“I will accept an offer of surgery because from the information we
received about glaucoma, surgery is the best option to avoid
blindness”.FGD 04 M38
“I have not rejected an offer of surgery from the hospital, but financial
constraints made me delay the surgery”. FGD 04-F45
Follow up
“Keeping follow up appointments will help us especially when we
have problems with the drug or in an instance of side effects”. FGD
04 M38
“You will come very early in the morning waiting to see the doctor,
but you spend the whole day because they are seeing people who
came after you, even if they are their staff or family. This is not fair
and I don’t want to quarrel again with anyone”. FGD 06-F62
Communicating about glaucoma
“I can inform others about glaucoma based on the information I have
received during this discussion”. FGD 06-M47
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look like engine oil that has lasted too long in a
motorcycle then it liquefies.” IDI 01–1
“My medicine makes the mucus dissolve like ice in
water. It burns out the oily layer formed in the eye
and the patient is cured…glaucoma cannot be treated
by surgical operation. There is no doctor on the
surface of this world that can convince me of that.”
ID I01-1
Adherence to medication
Most patients administered the drops themselves while a
few had help from carers. Many elderly patients said
they rely on their children, and women often relied on
their husbands to buy the drugs, having little or no con-
trol over when they would be available. Most respon-
dents admitted to not being very adherent to their
treatment regimes (Table 2), giving a range reasons in-
cluding lack of information about how to take their
treatment. For example,
“I was not told whether to continue or just administer
the drug when in need so I use it as occasion
demands.” FGD 06-F42.
Adherence to medication was also difficult due to costs
and also availability, particularly for those living in rural
areas who ended up purchasing drugs from other sources,
such as local pharmacies, where the potency of drugs can-
not be guaranteed.
The second commonest reason was forgetfulness or
preferring other treatment.
“We sometimes run short of money to buy the drugs”.
FGD 03-M61
“Sometimes the drugs are difficult to get from
the pharmacy shops, especially when the hospital
pharmacy runs short of the drugs. Sometimes the
drugs we buy outside the hospital pharmacy are not
as effective as the ones we buy at the hospital”.
FGD 02-M45
“I try to take the drugs as prescribed by the doctors,
but sometimes I do forget”. FGD 05-F59
Quite a few patients said that they only use their drugs
if they develop symptoms. Even though glaucoma has
few symptoms apart from loss of vision, some patients
claimed to know when the pressure is high as they de-
velop headaches. Some patients understood that treat-
ment preserved sight whereas others no longer used
medication, as they were already blind or had poor ad-
herence as they thought treatment should improve their
vision. Some participants did not adhere to medication
because of side effects such as headaches, hiccoughs, red
eyes, gritty eyes and poor sleep. Some feared complica-
tions later in life.
“I use the drugs but when I feel better I reduce the
frequency of using the drugs”. FGD 02-M43
“I have used the drugs for some time but there is no
change in my vision, so I don’t know whether the
drug is working or not”. FGD 06-F41
Acceptance of surgery
Most reasons for accepting or rejecting surgery were
based on the experiences of others. Some patients re-
ported that what they need is confidence in the doctor’s
advice and abilities, and a reliable, efficient service.
Fear of blindness, cost of surgery and the fear of surgery
itself were reasons for not accepting surgery in some.
“I will accept surgery but the doctor must be sure that
surgery is the best treatment for me”. FGD 03-M35
“There are difficulties in going to the hospital. One
could spend the whole day without seeing the doctor
then will be told to come back in a week or a month
after spending transportation money….” FGD 06-F55
“I am afraid of the surgery”. FGD 06-F65
Follow up
There was general agreement that follow up is important
because it will help the doctor address their problems
and monitor progress of their disease. Many patients did
not specify why they defaulted from follow up, explain-
ing that the reasons were beyond their control, for those
that did, lack of money, and negative attitudes of some
staff which may reflect their views about the inefficiency
of the service was a factor (Table 2).
“You will come very early in the morning waiting to
see the doctor, but you spend the whole day because
they are seeing people who came after you, even if
they are their staff or family. This is not fair and I
don’t want to quarrel again with anyone”. FGD 06-F62
Communicating about glaucoma
Most participants said that trained staff were in the best
position to educate people about glaucoma. More than
half said that glaucoma patients were in the best position
to enlighten others. Most respondents said that the best
means of creating awareness about glaucoma in the gen-
eral population is through the radio, television and
health talks whilst others mentioned household heads,
community leaders, health organisations and govern-
ment agencies (Table 2).
Discussion
This study explored patients’ understanding of glau-
coma, their health seeking behaviour and how they cope
with the disease and its treatment in everyday life in
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Bauchi, Nigeria. When illness strikes it is common in all
societies to ask, ‘why me? why now?’ [50]. These ques-
tions are challenging in glaucoma even with biomedical
knowledge, as the disease does not yet have a clear
underlying cause. Lay explanations in this study included
exposure to certain foods, wood smoke and crying, or
supernatural or fatalistic causes, implying that this is
what God had ordained for them. Eye care providers
need to be aware of these views, and be respectful and
considerate [50].
In this study some participants visited traditional
healers either when they first noticed problems with
their vision or once they had given up hope in allo-
pathic services. From the author’s experience, trad-
itional healers are respected and trusted in northern
Nigeria, having considerable influence on patients’ and
their carers’ decisions: indeed, the word of the trad-
itional healer is often believed above that of medical
doctors. In this study some participants believed that
traditional healers could cure their glaucoma. However,
other participants were of the view that traditional
healers could not be relied upon as they lack the ability
to make an accurate diagnosis. This is supported by the
interview with one healer who appeared to confuse
glaucoma with onchocerciasis, saying that it followed
the bite of a fly. This healer had confidence in his own
treatment and was emphatic that surgery was not appro-
priate for glaucoma. To our knowledge this is the first
study to interview traditional healers about glaucoma.
Understandings about glaucoma varied, with some
patients having very good knowledge of the condition
and its treatment whilst others had no awareness, hear-
ing details for the first time during the study. The lack
of a universally understood name for glaucoma in the
majority Hausa community reflects that it is not a well-
known disease. It is important to have a common no-
menclature that describes glaucoma so that it is not
mistaken for other treatable conditions such as cata-
ract, for example, which can have tragic consequences.
In this study the most fitting descriptions that correlate
with the biomedical definition of glaucoma were hawan
jinin ido (hypertension of the eye), and taka shanya
(stumbling on objects without having seen them). The
first derives from patients’ understanding of hyperten-
sion which is quite common in Nigeria [51], while the
second describes peripheral visual field loss typical of
glaucoma and onchocerciasis. These terms could be
used to create awareness in the community and in pa-
tient education, gradually introducing and popularizing
the term glaucoma, as has been suggested in Ghana
[52]. Lack of knowledge of glaucoma is commonly re-
ported from developing countries such as Ethiopia [39]
and India [44], but awareness can also be low in more
developed societies such as Brazil [53] and in the USA
[54]. Greater awareness has been reported amongst
those with higher levels of education [29] and is associ-
ated with more appropriate eye care seeking behaviour
[42, 43].
In the Netherlands improving knowledge was consid-
ered best delivered by qualified staff, or representatives
of glaucoma patients’ societies, which requires trust in
health professionals [55]. In our study some participants
recommended peer-to-peer methods as a means of en-
couraging others with glaucoma to accept treatment,
but there is the potential for misunderstandings to be
perpetuated. Glaucoma support groups or clubs could
also be formed, as have been established elsewhere, to
aid interaction among patients with a view to improv-
ing awareness, knowledge and adherence to treatment
[56]. Glaucoma support groups can also advocate for
better availability of affordable medication, and encour-
age others to be assessed for glaucoma [56].
In our study some participants did not understand
that the purpose of treatment is to preserve existing vi-
sion rather restore sight, which is one explanation for
low acceptance and adherence as there was no per-
ceived benefit. Other reasons included forgetfulness,
side effects and fear that long-term use would acceler-
ate blindness. Amongst those who did want to use
medication cost, lack of medication in hospital pharma-
cies and difficulty in instilling eye drops were described.
In this setting as elsewhere, these are legitimate chal-
lenges. Similar findings have been reported from Jamaica
and the Netherlands [27, 57].
Fear of a poor outcome was an important reason why
patients do not accept surgery. Combined cataract and
glaucoma surgery is being advocated for Africa, even if
there are only minimal lens opacities, so that patients
experience some improvement in vision after glaucoma
surgery [58]. Fear can be allayed in different ways: the
HIV/AIDS program in Ethiopia used entertainment edu-
cation to help patients cope with fear and to promote
preventive actions [59].
Adherence to eye drops requires using the drug at the
right time as well as delivering the drug into the eye,
which can be challenging [49]. Several studies have
shown deficiencies in self-administration of eye drops,
including in Baltimore where 29 % of glaucoma patients
were unable to instil their drops [60]. It is, therefore, es-
sential that patients use reliable systems to remind them
when to use their drops, and are trained to instil drops
themselves, or others administer the drops. The ex-
tended family system in Nigeria would make the latter a
feasible solution.
Adherence to medication in all chronic diseases is a
challenge, and many interventions have been evaluated
and could be adapted locally. Interventions include mo-
tivational strategies for hypertension [61], and education
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or counselling for latent tuberculosis [62]. Intensive re-
minders and ‘implementation intention’ interventions
appear promising in antiepileptic mediations [63] and
patient support and education for antiretroviral therapy
[64]. Although complex interventions consisting of pa-
tient education combined with personalised behavioural
change interventions, including tailoring daily routines
to promote adherence to eye drops, may improve adher-
ence in glaucoma there is insufficient evidence to rec-
ommend a particular intervention [65]. A major review
of use of education to improve adherence demonstrated
that educational interventions led to a significant im-
provement in medication adherence or a trend in im-
provement [66].
In our study several participants complained of ineffi-
cient services with long waiting times and poor attitudes
of staff, which made them reluctant to attend for follow
up. This needs to be addressed by reorienting and edu-
cating staff to be more patient friendly and by improving
patient care pathways.
Limitations
In this study only two traditional healers were inter-
viewed, and all patients had advanced glaucoma whose
views and experiences may differ from those with less
advanced disease. All participants came from northeast
Nigeria and the findings may not be applicable in other
regions of the country where levels of education and
socio-economic status are higher and where there are re-
ligious and cultural differences. Analysis was undertaken
using translations of the transcripts and some nuances
in meaning may have been lost, but the mother tongue
of the first author is Hausa.
Conclusions
Multiple interventions and approaches are required to
reduce glaucoma blindness, the “silent thief of sight”, in
Africa. Important elements include increasing awareness
using locally derived terms so that patients present earl-
ier; improving primary eye care for earlier detection and
referral; improving the education of glaucoma patients
about their disease and their role in controlling it; im-
proving the quality, capabilities and efficiency of services
and the attitudes of staff; ensuring the availability of af-
fordable eye drops and teaching patients or their carers
how to instil them, and evaluating interventions appro-
priate to Africa to improve adherence to topical medica-
tion, acceptance of surgery and long term follow up.
However, before demand for glaucoma services are
generated in the community, interventions are required
to improve the knowledge, acceptance and adherence to
treatment amongst patients who present to eye depart-
ments in Africa with glaucoma. The findings from this
study have been used to adapt a counselling technique
known as motivational interviewing for glaucoma in the
African context, which is being evaluated in a random-
ized controlled trial in ATBUTH [67].
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